Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2019-11-14 Regulatory Filings
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Allotment of ESOP/ESPS
Regulatory Filings Classification · 100% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 180 characters, indicating it is extremely short and contains no report content. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2019-11-14 English
The Operations and Administrative Committee of the Company on 13th November, 2019 has allotted 1,18,382 equity shares of Rs.2/- each pursuant to exercise of the stock options by the ....
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 180 characters, indicating it is extremely short and contains no report content. There is no indication of any report, announcement, or detailed information. Given the lack of content, the document cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or non-informative filings.
2019-11-14 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group (MUFG)
Major Shareholding Notification Classification · 100% confidence The document is a formal disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the sale of interest in Cipla Limited by Mitsubishi UFJ Financial Group and related entities, including specific shareholding percentages before and after the transaction. The document includes detailed tables of shareholding changes and references to regulatory thresholds for disclosure. This type of filing corresponds to notifications about changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes.
2019-11-13 English
The copy of the transcript of the Company''s Q2 FY20 earnings conference call dated 6th November, 2019. The transcript is also available on the Company''s website i.e. www.cipla.com ....
Regulatory Filings
2019-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2019-11-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 85% confidence The document lists dates, fund/investor names, venues, and types of meetings, such as in-person and call meetings, related to investor or capital market events. It appears to be a schedule or summary of investor meetings and conferences rather than a financial report, regulatory filing, or announcement. The content is consistent with an Investor Presentation or related investor communication material. Given the nature of the content focusing on investor meetings and conferences, the most appropriate classification is Investor Presentation (IP). The document length is short but contains detailed meeting information, not just an announcement of a report, so it is not a Report Publication Announcement (RPA).
2019-11-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.